A lung cancer gene GPC5 could also be crucial in breast cancer

Molecular Genetics and Metabolism

Volumn 103, Issue 1, 2011, Pages 104-105

  Zhang, Changwen ^a,b   Zhang, Shuping ^a   Zhang, Daoqiang ^c   Zhang, Zhihong ^b   Xu, Yong ^b   Liu, Sijin ^a  

^a RESEARCH CENTER FOR ECO ENVIRONMENTAL SCIENCES   (China)

^b SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

^c WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; GPC5; Lung cancer

Indexed keywords

BREAST CANCER; CANCER SURVIVAL; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GPC5 GENE; HUMAN; LETTER; LUNG ADENOCARCINOMA; LUNG CANCER; PRIORITY JOURNAL; TUMOR GENE;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYPICANS; HUMANS; LUNG NEOPLASMS;

EID: 79955162643     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.02.005     Document Type: Letter

References (9)

1. Kleeff J., Ishiwata T., Kumbasar A., Friess H., Buchler M.W., Lander A.D., Korc M. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J. Clin. Invest. 1998, 102:1662-1673.
2. Matsuda K., Maruyama H., Guo F., Kleeff J., Itakura J., Matsumoto Y., Lander A.D., Korc M. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res. 2001, 61:5562-5569.
3. Saikali Z., Sinnett D. Expression of glypican 3 (GPC3) in embryonal tumors. Int. J. Cancer 2000, 89:418-422.
4. Nakatsura T., Kageshita T., Ito S., Wakamatsu K., Monji M., Ikuta Y., Senju S., Ono T., Nishimura Y. Identification of glypican-3 as a novel tumor marker for melanoma. Clin. Cancer Res. 2004, 10:6612-6621.
5. Capurro M., Wanless I.R., Sherman M., Deboer G., Shi W., Miyoshi E., Filmus J. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003, 125:89-97.
6. Li Y., Sheu C.C., Ye Y., de Andrade M., Wang L., Chang S.C., Aubry M.C., Aakre J.A., Allen M.S., Chen F., Cunningham J.M., Deschamps C., et al. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol. 2010, 11:321-330.
7. Liu S., Goldstein R.H., Scepansky E.M., Rosenblatt M. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone. Cancer Res. 2009, 69:8742-8751.
8. van de Vijver M.J., He Y.D., van't Veer L.J., Dai H., Hart A.A., Voskuil D.W., Schreiber G.J., Peterse J.L., Roberts C., Marton M.J., Parrish M., Atsma D., et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 2002, 347:1999-2009.
9. Li Y., Yang P. GPC5 gene and its related pathways in lung cancer. J. Thorac. Oncol. 2011, 6:2-5.